"Amazon Bio Discovery enables scientists to run complex computational workflows through more than 40 AI-specialized foundational models, trained on a wide range of biological datasets. These models generate and evaluate potential drug molecules, alongside AI agents that help scientists to select models, optimize inputs and evaluate candidates according to their research."
"The Memorial Sloan Kettering Cancer Center, who recently partnered with Amazon Bio Discovery, states that they designed nearly 300,000 new antibody molecules and sent top 100,000 candidates for testing, enhancing the workflow timeframe from one year to just weeks."
"Rajiv Chopra, vice president of healthcare AI and life sciences at AWS, reportedly said that the service is intended to increase scientists and contract research organizations, instead of replacing them."
Amazon Bio Discovery is an AI bio tool launched by AWS to enhance drug discovery in the pharmaceutical industry. It allows scientists to run complex workflows using over 40 AI models trained on diverse biological datasets. The tool facilitates the generation and evaluation of drug molecules, optimizing inputs and evaluating candidates. Researchers can collaborate with lab partners for synthesis and testing, streamlining the process significantly. The platform addresses bottlenecks faced by computational biologists and bench scientists, providing access to computational design and wet-lab validation.
#ai-in-drug-discovery #amazon-bio-discovery #pharmaceutical-industry #computational-biology #biological-datasets
Read at TNW | Amazon
Unable to calculate read time
Collection
[
|
...
]